# Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer

> **NCT03565029** · PHASE2 · COMPLETED · sponsor: **Niguarda Hospital** · enrollment: 180 (actual)

## Conditions studied

- Colo-rectal Cancer

## Interventions

- **DRUG:** XELOX
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT03565029
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2023-12-20
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565029, "Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03565029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*